Shire Settles Adderall XR Patent Case With Impax, But Remains At Impasse With Barr
This article was originally published in The Pink Sheet Daily
Executive Summary
If a generic amphetamine extended-release launches before 2010, Impax will sell Shire’s authorized generic.
You may also be interested in...
Vyvanse Adds 14-Hour Duration Data As Shire's ADHD Drugs Face Off With Generics
Duration of use data will help to strengthen Vyvanse's position in the fast-growing adult segment, Shire says.
Vyvanse Adds 14-Hour Duration Data As Shire's ADHD Drugs Face Off With Generics
Duration of use data will help to strengthen Vyvanse's position in the fast-growing adult segment, Shire says.
Shire Patent Infringement Suit Over Adderall XR Triggers 30-Month Stay
Stay of FDA action on Andrx' ANDA will extend beyond Barr's entry, Shire says.